Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (751-760 of 818) with videos related to

Pageof 82
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998D J Diekema, M A Pfaller, J Turnidge, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in BrazilJ N Rodrigues, J L Amaral, I L Leme, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology|August 30, 2001
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance programM A Pfaller, D J Diekema, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1981
Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parametersJ D Sink, G L Pellom, W D Currie, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
Pageof 82

Showing results (751-760 of 818) with videos related to

Sort By:
Pageof 82
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998D J Diekema, M A Pfaller, J Turnidge, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in BrazilJ N Rodrigues, J L Amaral, I L Leme, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology|August 30, 2001
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance programM A Pfaller, D J Diekema, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1981
Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parametersJ D Sink, G L Pellom, W D Currie, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centersH S Sader, R N Jones, J A Washington, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
Pageof 82